| Patents for A61P 39 - General protective or antinoxious agents (19,019) |
|---|
| 02/28/2001 | CN1062461C Senility-resistant health medicine |
| 02/27/2001 | US6194404 Process for the isolation of galanthamine |
| 02/27/2001 | US6194020 Conserving procyanidins(catechins); candy |
| 02/22/2001 | WO2001012832A1 Process for producing lycopen |
| 02/22/2001 | WO2001012775A2 25 human secreted proteins |
| 02/22/2001 | WO2001012603A1 Indole derivatives, process for their preparation, pharmaceutical compositions containing them and their medicinal application |
| 02/22/2001 | WO2001012202A2 Use of chemical chelators as reversal agents for drug-induced neuromuscular block |
| 02/22/2001 | WO2001012168A2 Antiviral pharmaceutical compositions containing iron chelators |
| 02/22/2001 | WO2001012127A2 TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR |
| 02/22/2001 | WO2000073330A3 Method and compositions relating to insulin resistance disorders |
| 02/22/2001 | CA2382148A1 25 human secreted proteins |
| 02/22/2001 | CA2380635A1 Tgf-.alpha. polypeptides, functional fragments and methods of use therefor |
| 02/22/2001 | CA2377646A1 Indole derivatives, process for their preparation, pharmaceutical compositions containing them and their medicinal application |
| 02/21/2001 | CN1284371A Natural health care ointment and its preparation |
| 02/21/2001 | CN1062168C Medicine for eliminating toxicity and side-effect casused by chemotherapy curing treating cancer |
| 02/20/2001 | US6190685 Antioxidizing composition for scavenging free radicals, pharmaceutical composition comprising the same, and process for preparing the same |
| 02/15/2001 | WO2001010901A2 Antimicrobial histone h1 compositions, kits, and methods of use thereof |
| 02/15/2001 | WO2001010865A1 p38MAP KINASE INHIBITORS |
| 02/15/2001 | WO2000064957A3 Differentially acting op detoxifying sponges |
| 02/15/2001 | WO2000062740A3 Skin care compositions containing combination of skin care actives |
| 02/15/2001 | WO2000011204A3 Homer interacting proteins |
| 02/15/2001 | CA2381215A1 P38map kinase inhibitors |
| 02/15/2001 | CA2379087A1 Antimicrobial histone h1 compositions, kits, and methods of use thereof |
| 02/14/2001 | EP1075281A2 Polyol-ifn-beta conjugates |
| 02/14/2001 | EP1075256A1 Arylhydrocarbon receptor ligand antagonists |
| 02/14/2001 | CN1283994A Methods for treatment of neuro-and nephro-disorders and therapeutic toxicities using aminothiol compounds |
| 02/14/2001 | CN1283503A Oral liquid of gingko |
| 02/14/2001 | CN1283497A Oral liquid for treating cerebrovascular disease and its preparing process |
| 02/14/2001 | CN1283418A Compound chitosane for additive for discharging lead |
| 02/14/2001 | CN1061986C Prepn of grouped gensenoside, its medicinal compsn and use |
| 02/13/2001 | US6187745 Co-administration of a pentosan polysulfate (pps) or a pharmaceutically acceptable salt thereof. |
| 02/08/2001 | WO2001009132A1 C-6 RING-SUBSTITUTED PYRIDO[1,2-a]BENZIMIDAZOLE DERIVATIVES USEFUL IN TREATING CENTRAL NERVOUS SYSTEM DISORDERS |
| 02/08/2001 | WO2001009097A1 Cyclic amine derivatives for the treatment of neurological diseases |
| 02/08/2001 | WO2001008679A1 A method to increase the excretion of non-sterol endogenous hydrophobic substances by increasing excretion of fat via the faeces |
| 02/08/2001 | WO2001008657A2 Personal care articles |
| 02/08/2001 | WO2000058295A3 Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 02/08/2001 | CA2391766A1 C-6 ring-substituted pyrido¬1,2-a|benzimidazole derivatives usefu l in treating central nervous system disorders |
| 02/08/2001 | CA2379538A1 Personal care articles |
| 02/08/2001 | CA2345753A1 A method to increase the excretion of non-sterol endogenous hydrophobic substances by increasing excretion of fat via the faeces |
| 02/07/2001 | EP1073471A1 Method of treating endotoxemia |
| 02/07/2001 | EP0538422B1 New use of diphenylbutylpiperazinecarboxamides in the treatment of substance disorders |
| 02/07/2001 | CN1283119A Pharmaceutical composition comprising ticlopidine and ginkgo biloba extract |
| 02/07/2001 | CN1283083A Revitalisation formulation |
| 02/07/2001 | CN1282602A Antifatigue capsule |
| 02/06/2001 | US6184227 Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases |
| 02/06/2001 | US6184013 Antibody for reducing concentration of drug in patient |
| 02/01/2001 | WO2001007440A1 Imidazoimidazoles and triazoles as anti-inflammatory agents |
| 02/01/2001 | WO2001007069A1 In vivo induction for enhanced function of isolated hepatocytes |
| 02/01/2001 | WO2000059493A3 Improved dialysis solutions and methods |
| 02/01/2001 | CA2383017A1 Imidazoimidazoles and triazoles as anti-inflammatory agents |
| 01/31/2001 | EP1072604A1 Calcium complex of (4R)-4-bis(carboxy-kappa.O)methyl amino-.kappa.N-6,9-bis (carboxy-.kappa.O)methyl-1-(4,4-diphenylcyclohexyl)oxy-1-hydroxy-2-oxa-6,9-diaza-1-phosphaundecan- 11-yl acid-.kappa.N6,.kappa.N9,.kappa.O11 1-oxidato(6-)-,hexahydrogen, corresponding salts, pharmaceutical composition containing such complex, its therapeutic use and its use as additive as diagnostic agent as well as a process for preparing the complex |
| 01/31/2001 | EP1072265A1 Use of plant polyphenols for treating iron overload |
| 01/31/2001 | EP1072255A2 Desferrioxamine oral delivery system |
| 01/31/2001 | EP1071474A1 Substituted porphyrins |
| 01/31/2001 | EP1071430A1 Treatment of iatrogenic and age-related hypertension with vitamin b6 derivatives and pharmaceutical compositions useful therein |
| 01/31/2001 | EP1071419A1 Cannabinoids as antioxidants and neuroprotectants |
| 01/31/2001 | EP1071414A1 Compounds and methods for treating mitochondria-associated diseases |
| 01/31/2001 | CN1061350C 2.7-substituted octahydro-pyrrolo (1.2-A) pyrazine derivatives |
| 01/30/2001 | US6180667 Esters of acyl L-carnitines and pharmaceutical compositions containing same for treating endotoxic shock |
| 01/30/2001 | US6180664 Pentaerythritol derivatives, their production and use and intermediates for their synthesis |
| 01/30/2001 | US6180116 Histidine derivatives, preparation process and uses |
| 01/25/2001 | WO2001005411A1 Compositions addressing inflammation and/or degenerative disorders |
| 01/25/2001 | WO2001005368A1 Use of at least one extract of a plant of the genus lannea in a cosmetic or dermopharmaceutical composition |
| 01/25/2001 | WO2000059946A8 Hydroxymatairesinol in cancer prevention |
| 01/25/2001 | WO2000054756A3 Nitrate esters and their use for introducing neuroprotection and cognition enhancement |
| 01/24/2001 | CN1280854A Detoxicating nutritive liquor and its preparing process |
| 01/23/2001 | US6177419 Antioxidant chelate compounds for preventing oxygen free radical-associated diseases in mammals; neuroprotectants, superoxide dismutase (sod), catalase (cat) and/or peroxidase (pod) mimetics |
| 01/18/2001 | WO2001004297A2 Human proteins having hydrophobic domains and dnas encoding these proteins |
| 01/18/2001 | WO2001003699A1 Medicament with a protective effect against oxidative-toxic substances, particularly against cardiotoxic substances |
| 01/18/2001 | DE19932555A1 Arzneimittel mit protektiver Wirkung gegen oxidativ-toxische und insbesondere gegen kardiotoxische Substanzen Drugs with a protective effect against oxidative-toxic and in particular against cardiotoxic substances |
| 01/17/2001 | EP1068869A2 Method and composition for ameliorating tissue damage due to ischemia and reperfusion |
| 01/17/2001 | CN1280008A Strong anti-oxidative composite capsule of grape seed extract OPC and its producing method |
| 01/17/2001 | CN1279978A Ginkgo and gastrodia taber capsule |
| 01/17/2001 | CN1060657C Nouring medicine for preventing and curing toxic and side effect after tumor radiotherapy |
| 01/16/2001 | US6174890 A synergistic biological, neurometabolic and celltrophic composition comprising antioxidative and -catabolic stress (methionine),-anabolic drugs, vasodilative and normo-lipidemic drugs (nicotinic acid), energoactive and antitoxic |
| 01/11/2001 | WO2001002571A2 An interleukin-1 receptor antagonist and uses thereof |
| 01/11/2001 | WO2001002405A1 Quinuclidine derivatives for treatment of neurological disorders |
| 01/11/2001 | WO2001002391A2 Bicyclic aromatic compounds for treating drug addiction |
| 01/11/2001 | WO2001002368A1 N-heterocyclic derivatives with neuronal activity |
| 01/11/2001 | WO2001001988A1 Compounds having cytokine inhibitory activity |
| 01/11/2001 | WO2001001986A1 Method of reducing neuronal injury or apoptosis |
| 01/11/2001 | WO2001001979A1 Therapeutic agents |
| 01/11/2001 | WO2001001973A2 Highly selective norepinephrine reuptake inhibitors and methods of using the same |
| 01/11/2001 | WO2001001940A1 Compositions comprising organosiloxane resins for delivering oral care substances |
| 01/11/2001 | WO2001001932A2 Oligosaccharide aldonic acids and their topical use |
| 01/11/2001 | WO2000053215A3 Deglycosylated ricin toxin a-chain vaccine |
| 01/11/2001 | CA2643231A1 Norepinephrine reuptake inhibitors and methods of using the same |
| 01/11/2001 | CA2378389A1 Therapeutic agents |
| 01/11/2001 | CA2376513A1 An interleukin-1 receptor antagonist and uses thereof |
| 01/11/2001 | CA2373883A1 Method of reducing neuronal injury or apoptosis |
| 01/11/2001 | CA2373882A1 Compounds having cytokine inhibitory activity |
| 01/10/2001 | EP1066835A1 Composition containing the pepino extracts for lowering the concentration of alcohol in the blood and method for producing the same |
| 01/10/2001 | EP1066277A1 Polyethoxylated ascorbic acid derivatives as a novel antioxidant and process for preparing thereof |
| 01/10/2001 | CN1279605A Inihibition of lipoprotein oxidation |
| 01/10/2001 | CN1279073A Antisenility Chinese medicine |
| 01/10/2001 | CN1279037A Health-care tonic canned food |
| 01/10/2001 | CN1060359C Complete Chinese medical preparation for chronic fatigue syndrome and process thereof |
| 01/09/2001 | US6172067 Analgesics, antiinflammatory agents |
| 01/04/2001 | WO2001000812A2 22012, a novel human carboxypeptidase |
| 01/04/2001 | WO2001000193A2 Zinc ionophores as anti-apoptotic agents |